close

Fundraisings and IPOs

1 2 3 4 5 72
Number of results: 1432
Date Company Amount Funding type Investors Therapeutic area Type of Information
2018-04-27 A-Mansia (Belgium) €13 million series A financing round Seventure (France) Fonds Vives II (Belgium) SRIW Life Sciences (Belgium) Nivelinvest (Belgium) Pierre Drion Metabolic diseases Series A financing round
2018-04-26 Mereo BioPharma (UK) IPO Rare diseases - Genetic diseases IPO
2018-04-19 Tmunity Therapeutics (USA - PA) $135 million series A financing round Kleiner Perkins (USA) Ping An Ventures (China) Parker Institute for Cancer Immunotherapy (USA - CA) Gilead Sciences, (USA - CA) Be The Match BioTherapies (USA - MN) University of Pennsylvania (USA - PA) Lilly Asia Ventures (China) Cancer - Oncology Series A financing round
2018-04-02 ITBMed (Sweden) up to $67 million financing round Royalty Pharma (US - NY) Transplantation Financing round
2018-03-27 Poietis (France) €5 million series A financing round, grant WiSEED (France) Nouvelle Aquitaine Coinvestment Fund (France) Technology - Services Series A financing round
2018-02-23 Fate Therapeutics (USA - CA) $4 million grant California Institute for Regenerative Medicine (CIRM) (USA - CA) Cancer - Oncology Grant
2018-02-23 Fate Therapeutics (USA - CA) $4 million grant California Institute for Regenerative Medicine (CIRM) (USA - CA) Cancer - Oncology Grant
2018-02-16 ABAC Therapeutics (Spain) €16 million series A financing round Pontifax (Israel) Quark Venture (Canada) GF Securities (China) Caixa Capital Risc (Spain) Debiopharm Innovation Fund (Switzerland) Ferrer (Spain) Infectious diseases Series A financing round
2018-02-07 Sangamo Therapeutics (USA - CA) Case Western Research University (USA - OH) $11 million grant National Institutes of Health (NIH) (USA) Infectious diseases Grant
2018-02-05 Metrion Biosciences (UK) £200 000 grant Innovate UK Biomedical Catalyst Feasibility Award scheme (UK) Autoimmune diseases - Neurodegenerative diseases Grant
2018-02-02 Viking Therapeutics (USA - PA) $55 million private placement Endocrinological diseases - Metabolic diseases Private placement
2018-02-02 Medivir (Sweden) 155 million SEK (€ 15.75 million) Infectious diseases Private placement
2018-02-01 Avrobio (USA - MA) $60 million series B financing round Cormorant Asset Management and Surveyor Capital (a Citadel company), and included participation by Aisling, Brace Pharma Capital, Eventide Asset Management and Morningside, along with existing investors Atlas Venture, SV Health Investors and Clarus Ventures. Cancer - Oncology - Rare diseases - Genetic diseases Series B financing round
2018-01-29 Audentes Therapeutics (USA - CA) $231.4 million private placement Rare diseases - Genetic diseases Private placement
2018-01-23 Tmunity Therapeutics (USA - PA) $ 100 million series A financing round Ping An Ventures (China) Parker Institute for Cancer Immunotherapy (USA - CA) Gilead Sciences (USA - CA) Be The Match BioTherapies University of Pennsylvania (USA - PA) Lilly Asia Ventures (China) Cancer - Oncology - Autoimmune diseases - Infectious diseases Series A financing round
2018-01-23 Skyhawk Therapeutics (USA - MA) $ 8 million financing round Tim Disney, the Duke of Bedford, Alexandria Venture Investments (USA - MA) and other undisclosed private investors Cancer - Oncology - Neurological diseases Financing round
2018-01-23 Ultragenyx Pharmaceutical (USA - CA) $250 million private placement Rare diseases - Genetic diseases Private placement
2018-01-22 Avexis (USA - IL) $431.9 million private placement Rare diseases - Genetic diseases - Neuromuscular diseases Private placement
2018-01-22 Beigene (China) $800 million private placement Cancer - Oncology Private placement
2018-01-16 Arbutus Biopharma (Canada) US$116.4 million private placement Roivant Sciences (CH - USA) Infectious diseases Private placement